John C. Martin
2015 - Gilead Sciences
In 2015, John C. Martin earned a total compensation of $18.8M as Chairman and Chief Executive Officer at Gilead Sciences, a 1% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $4,038,525 |
|---|---|
| Option Awards | $5,749,850 |
| Salary | $1,727,423 |
| Stock Awards | $7,232,654 |
| Other | $7,500 |
| Total | $18,755,952 |
Martin received $7.2M in stock awards, accounting for 39% of the total pay in 2015.
Martin also received $4M in non-equity incentive plan, $5.7M in option awards, $1.7M in salary and $7.5K in other compensation.
Rankings
In 2015, John C. Martin's compensation ranked 130th out of 13,638 executives tracked by ExecPay. In other words, Martin earned more than 99.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 130 out of 13,638 | 99th |
Division Manufacturing | 47 out of 5,190 | 99th |
Major group Chemicals And Allied Products | 24 out of 1,854 | 99th |
Industry group Drugs | 22 out of 1,528 | 99th |
Industry Biological Products, Except Diagnostic Substances | 3 out of 254 | 99th |
Source: SEC filing on March 28, 2016.
Martin's colleagues
We found four more compensation records of executives who worked with John C. Martin at Gilead Sciences in 2015.